Best treatments for urinary tract infections (UTI)
7 products may treat urinary tract infections (also known as UTI), spanning FDA drug classes such as triazaacenaphthylene bacterial type ii topoisomerase inhibitor, cephalosporin antibacterial, oxidation-reduction agent. The current highest-rated option is blujepa. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 7 drugs we list for urinary tract infections, none are yet flagged as generics in our price data, spanning classes such as triazaacenaphthylene bacterial type ii topoisomerase inhibitor, cephalosporin antibacterial, oxidation-reduction agent. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for urinary tract infections — so confirm the right choice with your prescriber.
New to this? See the plain-language over-the-counter & self-care guide →
Understanding urinary tract infections
A urinary tract infection (UTI) is an infection of the urinary tract, which includes the bladder, urethra, ureters, and kidneys. According to the CDC, UTIs happen when bacteria, often from the skin or rectum, enter the urethra and infect the urinary tract. Most infections settle in the bladder (cystitis), but they can spread upward to the kidneys, which is less common but more serious (pyelonephritis). UTIs are more common in women because the urethra is shorter and closer to the rectum. Common bladder-infection symptoms include pain or burning while urinating, needing to urinate frequently or urgently, cloudy or bloody urine, and pressure or cramping in the lower abdomen or back. Fever, chills, pain in the side or lower back, and nausea or vomiting can signal a kidney infection. Clinicians assess symptoms and may test the urine: a urinalysis looks for white blood cells, red blood cells, bacteria, and nitrites, and a urine culture can identify the bacteria and guide antibiotic choice. Most UTIs are treated at home with antibiotics prescribed by a healthcare provider. This is general information, not medical advice.
First-line treatment
For acute uncomplicated bladder infection (cystitis) in women, the joint IDSA/ESCMID guideline lists several first-line antibiotic options, and a clinician selects among them based on the individual, local bacterial resistance patterns, allergies, and other factors. Nitrofurantoin is considered an appropriate first choice because of minimal resistance and efficacy comparable to a short course of trimethoprim-sulfamethoxazole. Trimethoprim-sulfamethoxazole is appropriate where local resistance among the bacteria causing cystitis does not exceed about 20% (a threshold based on expert opinion). Fosfomycin is another appropriate option where available. Pivmecillinam is also first-line in regions where it is available, mainly some European countries; it is not licensed or available in North America. The CDC notes that antibiotics can cause side effects, so treatment should be prescribed and monitored by a healthcare provider. This is general information, not medical advice.
Get treated for urinary tract infections online
Licensed online providers — consult & get prescribed if eligible.
Advertising disclosure: We may earn a commission, at no extra cost to you. This never affects our ratings. Details
Top-rated picks for urinary tract infections: 1. Blujepa · 2. Cayston · 3. Fetroja
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 70/100 | Prescription | Tablet | Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor | No data | — | View → | |
| 2 | 70/100 | Prescription | Kit | — | No data | — | View → | |
| 3 | 70/100 | Prescription | Injectable | Cephalosporin Antibacterial | No data | — | View → | |
| 4 | Not yet rated | Prescription | Injectable | — | No data | — | View → | |
| 5 | Not yet rated | Prescription | Tablet | — | No data | — | View → | |
| 6 | Not yet rated | Prescription | Injectable | Oxidation-Reduction Agent | No data | — | View → | |
| 7 | Not yet rated | Prescription | Injectable | Oxidation-Reduction Agent | No data | — | View → |
Narrow by drug class
Explore the class hubs: oxidation-reduction agent
Full ranking · 7 treatments
blujepa
PrescriptionFDA-sourced
Blujepa (Gepotidacin Mesylate) is a triazaacenaphthylene bacterial type ii topoisomerase inhibitor used to treat Urinary Tract Infections.
cayston
PrescriptionFDA-sourced
Cayston (Aztreonam) is a medication used to treat Cellulitis, Endometritis, Pseudomonas Infections, Respiratory Tract Infections.
fetroja
PrescriptionFDA-sourced
Fetroja (Cefiderocol Sulfate Tosylate) is a cephalosporin antibacterial used to treat Bacterial Infections, Pyelonephritis, Urinary Tract Infections.
azactam
PrescriptionFDA-sourced
Azactam (Aztreonam) is a medication used to treat Cellulitis, Endometritis, Pseudomonas Infections, Respiratory Tract Infections.
lithostat
PrescriptionFDA-sourced
Lithostat (Acetohydroxamic Acid) is a medication used to treat Urinary Tract Infections.
methylene blue
Boxed warningPrescriptionFDA-sourced
Methylene Blue is an oxidation-reduction agent used to treat Cyanosis, Herpes Simplex, Methemoglobinemia, Poisoning.
Frequently asked
- What is the best medication for UTI?
- UTI is urinary tract infections. There isn't a single "best" medication for everyone — For acute uncomplicated bladder infection (cystitis) in women, the joint IDSA/ESCMID guideline lists several first-line antibiotic options, and a clinician selects among them based on the individual, local bacterial resistance patterns, allergies, and other factors. Nitrofurantoin is considered an appropriate first choice because of minimal resistance and efficacy comparable to a short course of trimethoprim-sulfamethoxazole. Trimethoprim-sulfamethoxazole is appropriate where local resistance among the bacteria causing cystitis does not exceed about 20% (a threshold based on expert opinion). Fosfomycin is another appropriate option where available. Pivmecillinam is also first-line in regions where it is available, mainly some European countries; it is not licensed or available in North America. The CDC notes that antibiotics can cause side effects, so treatment should be prescribed and monitored by a healthcare provider. This is general information, not medical advice.. Compare every option ranked above by our independent recall-safety rating (not an efficacy measure); this is general information, not medical advice.
- What treats urinary tract infections?
- Our catalog lists 7 products that may treat urinary tract infections, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is blujepa.
- What is the best-rated treatment for urinary tract infections?
- By our independent recall-safety rating — not an efficacy measure — blujepa ranks highest among the products we list for urinary tract infections. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat urinary tract infections?
- Treatments for urinary tract infections span FDA drug classes including triazaacenaphthylene bacterial type ii topoisomerase inhibitor, cephalosporin antibacterial, oxidation-reduction agent. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Sources
The clinical overview above is written from these authoritative public-health and medical-society sources, independently reviewed against each.
- Urinary tract infection – adults (MedlinePlus Medical Encyclopedia, U.S. National Library of Medicine) ↗
- Urinary Tract Infection Basics (Centers for Disease Control and Prevention, CDC) ↗
- International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases (Clinical Infectious Diseases / IDSA) ↗